ANTIBIOTIC RESISTANCE PHENOTYPES OF PSEUDOMONAS AERUGINOSA STRAINS ISOLATED IN AN EMERGENCY HOSPITAL
October 20, 2019
 |
Read full article |
| Article Title: | ANTIBIOTIC RESISTANCE PHENOTYPES OF PSEUDOMONAS AERUGINOSA STRAINS ISOLATED IN AN EMERGENCY HOSPITAL |
| Authors: | Daniela T. Marți 1, 2, Monica Șușan 3, Viorica Lazăr 1, 2, Liliana R. Bran 4, Mirela Ardelean 5, Carmen Neamțu 1, 2, Lucian Negruțiu1, Adrian Crișan 1, 2, Răzvan Șușan 3, Alexandru Fica Mircea Onel 1, 2, Cătălin Hreniuc1, 2, Daniel Răducan 1 |
| Affiliation: | 1 Faculty of Medicine, ,,Vasile Goldis” Western University of Arad, 2 The Clinical Emergency Hospital of Arad County, 3 ,,Victor Babeş” University of Medicine and Pharmacy Timişoara, 4 University “Aurel Vlaicu” of Arad, 5 „Vasile Goldiş” Western University of Arad, Institute of Life Science |
| Abstract: | The study of antibiotic resistance phenotypes of 105 Pseudomonas aeruginosa strains isolated from inpatients and outpatients. The resistance profile on antibiotic classes reflects the multidrug-resistance of the bacteria: 56,19% of the strains are resistant to fluororquinolones and aminoglycosides; 54,28% are ceftazidime-resistant strains; 47,61 are crabapenem resistant; 46,66 % showed resistance to piperacilin-tazobactam and colistin – resistance. |
| Keywords: | Pseudomonas aeruginosa, resistance phenotypes |
| References: | 1. Delia Mira Berceanu – Văduva, “ Curs de bacteriologie specială”, Ediția a II-a revizuită, Editura „Victor Babeș”, Timișoara, 2018, p. 56-57. 2. Doina Iovănescu, Cleo Roșculeț, C. Apostolecu, Cosmina Andrei, Dalila Toma, Catrinel Ciuca, Viorica Metescu, T. Vlădoiu, C. Camburu, Bogdana Manu, “Pozițiă centrală a patologiei infecțioase în ansamblul patologiei medicale în serviciile de terapie intensivă non-chirurgicală”, “Patologia infecțioasă la moment de răscruce”, Ediția a III –a , Editura “Gr. Popa”, U.M.F Iași, Iași, 2017, p. 66-68. 3. Matthew E. Falagas, Patra K. Koletsi and Ioannis A. Bliziotes, „The diversity of definitions of multidrug– resistance (MDR) and pandrug–resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa” Journal of Medical Microbiology, 2006, 55, p. 1619 – 1626. 4. van Duin D, Bonomo RA, “Ceftazidime/ Avibactam and Ceftolozane/ Tazobactam: Second generation beta-lactam/ beta-lactamase inhibitor combinations”. Clin Infect Dis, 2016, 63:234-241.doi:10.1093/cid/ciw 243 [PMC free article] [PubMed] [CrossRef]. 5. Stanca Lucia Pandrea, Lia Monica Junie, Clujul Medical 2011 Vol. 84 – nr. 1, p. 9-12. 6. Eucast 2018, „The European Commitee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 8.0, 2018. http://www.eucast.org 7. Popescu G.Adrian, Șerban Roxana, Pistol Adriana, “Consumul de antibiotice, Rezistența microbiană și Infecții Nosocomiale în România – 2014”, București 2016, http://www.cnscbt.ro, p. 37-39. 8. https://atlas.ecdc.europa.eu 9. Szekely Edit, Szasz I. Eva, Vas K. Eszter et al, “Providencia stuartii – o Protacee de success la orizont”, A IX A Conferință Națională de Microbiologie și Epidemiologie – 2016, p. 41-42. |
| *Correspondence: |
About The Author
